These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9517399)

  • 21. Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
    Fan LW; Tien LT; Tanaka S; Sasaki K; Park Y; Ma T; Rockhold RW; Ho IK
    J Neurosci Res; 2003 Jun; 72(6):781-9. PubMed ID: 12774318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
    Hooshmand B; Azizi H; Javan M; Semnanian S
    Neurosci Lett; 2017 Jan; 636():276-281. PubMed ID: 27816550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of physical and psychological dependence on butorphanol.
    Harshe DG; Mate OS; Cholera RM; Kale S
    J Opioid Manag; 2015; 11(2):112-3. PubMed ID: 26035913
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of nor-binaltorphimine on butorphanol dependence.
    Jaw SP; Makimura M; Hoskins B; Ho IK
    Eur J Pharmacol; 1993 Aug; 239(1-3):133-40. PubMed ID: 8223888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term glutamate desensitization in locus coeruleus neurons and its role in opiate withdrawal.
    Kogan JH; Aghajanian GK
    Brain Res; 1995 Aug; 689(1):111-21. PubMed ID: 8528694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):17-30. PubMed ID: 10933337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome.
    Tokuyama S; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid-glutamate interactions in rat locus coeruleus neurons.
    Oleskevich S; Clements JD; Williams JT
    J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure.
    Van Bockstaele EJ; Menko AS; Drolet G
    Mol Neurobiol; 2001; 23(2-3):155-71. PubMed ID: 11817217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid antagonists and butorphanol dependence.
    Jaw SP; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1993 Mar; 44(3):497-500. PubMed ID: 8383850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excitatory amino acid receptors are involved in morphine-induced synchronous oscillatory discharges in the locus coeruleus of rats.
    Zhu H; Zhou W
    Eur J Pharmacol; 2005 Dec; 528(1-3):73-8. PubMed ID: 16316646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local opiate withdrawal in locus coeruleus neurons in vitro.
    Ivanov A; Aston-Jones G
    J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors.
    Commiskey S; Fan LW; Ho IK; Rockhold RW
    J Pharmacol Sci; 2005 Jun; 98(2):109-16. PubMed ID: 15942128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supersensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence.
    Wongchanapai W; Tsang BK; He Z; Ma T; Ho IK
    Life Sci; 1998; 63(24):2175-80. PubMed ID: 9851309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence.
    Chaijale NN; Curtis AL; Wood SK; Zhang XY; Bhatnagar S; Reyes BA; Van Bockstaele EJ; Valentino RJ
    Neuropsychopharmacology; 2013 Sep; 38(10):1833-43. PubMed ID: 23660707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
    Zhang J; Haddad GG; Xia Y
    Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.